Free Trial
Don't Let the A.I. Investing Revolution Pass You By!Ends Tomorrow - Get 30 Days Free

Crinetics Pharmaceuticals (CRNX) SEC Filings & 10K Form

Crinetics Pharmaceuticals logo
$42.31 -1.84 (-4.17%)
Closing price 04:00 PM Eastern
Extended Trading
$42.50 +0.18 (+0.44%)
As of 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Crinetics Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
10/03/2025
3:41 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2025
3:30 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2025
3:41 PM		Crinetics Pharmaceuticals (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2025
3:42 PM		Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2025
3:27 PM		Crinetics Pharmaceuticals (Subject)
Fust Matthew K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2025
3:09 PM		Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2025
4:36 PM		Crinetics Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SCHEDULE 13G
09/04/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025
3:41 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2025
3:44 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
3:24 PM		Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
9:34 AM		Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
06/26/2025
3:16 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:30 PM		Crinetics Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
3:33 PM		Crinetics Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
3:36 PM		Crinetics Pharmaceuticals (Filer)
Form ARS
04/07/2025
10:52 AM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
03/21/2025
5:31 PM		Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:32 PM		Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:33 PM		Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:34 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Schilke Tobin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
3:23 PM		Crinetics Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:23 PM		Crinetics Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:10 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM		Crinetics Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
7:50 AM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
9:25 AM		Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:06 AM		Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:23 AM		Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/30/2025
8:33 PM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/29/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM		Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/14/2025
4:02 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:34 AM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM		Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:32 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:07 AM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:06 PM		Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:30 PM		Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:55 PM		Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM		Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
1:26 PM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM		Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
10:20 AM		Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:47 AM		Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:08 PM		Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CRNX) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners
Building The Infrastructure for the Coming Financial Reset
While China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...
Intellistake | Sponsoredtc pixel
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...
Huge Alerts | Sponsoredtc pixel
REVEALED: Something Big Happening Behind White House Doors
What I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...
Brownstone Research | Sponsoredtc pixel
Nvidia CEO’s Regret: ‘I Wish I Gave [Elon] More’…
Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...
Altimetry | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Melt-up warning
Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...
Porter & Company | Sponsoredtc pixel
Miss This IRS Strategy Now, Regret It Later
With Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...
American Alternative | Sponsoredtc pixel